LIVE

NRC

National Research Corporation

NRC

NASDAQ·Healthcare·Medical - Healthcare Information Services·Mkt cap $503.5M

$22.40

▲ +0.27%

View full research view

Our plain-language verdict, the thesis, risk factors, and what is changing about the business.

View research view

52-Week Range

$11.01 - $22.79

P/E

54.94

Fwd P/E

25.45

Beta

0.40

Div Yield

2.69%

Avg Vol

119.5K

Shares Out

22.7M

Mkt Cap

$503.5M

Price action

Price chart

Up 35.1% over the trailing year

1W
1M
3M
6M
YTD
1Y
5Y
MAX

Total returns

Price performance

Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.

Why we rate it this way

The thesis at a glance

Bull and bear case · plain-English context across the five lenses we evaluate.

▲

Bull Case

6 reasons

  • 40+ years of healthcare analytics expertise and established market presence
  • Comprehensive, integrated platform addressing multiple mission-critical healthcare functions
  • Subscription-based recurring revenue model with high customer retention
  • Deep relationships with integrated health systems, post-acute providers, and payers
  • Proprietary data and benchmarking capabilities across U.S. and Canadian markets
  • Real-time competitive assessment and segmentation tools for strategic decision-making
▼

Bear Case

2 risks

  • Low volatility (beta 0.4).
  • Premium valuation to Healthcare IT & Services peers

Growth

Mild headwinds expected

Increasing healthcare focus on patient experience and satisfaction metrics

Value

Premium valuation to Healthcare IT & Services peers

Momentum

Hot

+30.2% over 3m

Quality

Strong

Excellent business quality

Dividend

Solid

2.69% yield

Earnings track record

Recent earnings results

AI-summarized recap of last quarter, plus the surprise on every print.

Next: Apr 27, 2026

“
Q2 26 RECAP

APR 28, 2026

Earnings recap unavailable for this period.

EPS surprise · last 4Q

0 of 1 beats

Q2 26

—

Next: Apr 27, 2026

Revenue trend · last 8Q

—

—

-3%

-5%

-3%

-3%

-5%

+4%

Q2 24

Q3 24

Q4 24

Q1 25

Q2 25

Q3 25

Q4 25

Q1 26

$35.0M

$35.8M

$36.9M

$33.6M

$34.0M

$34.6M

$35.2M

$34.8M

Margins · last 8Q

Gross

—

Operating

—

Profit

9.3%

View full earnings history →

Wall Street consensus

1 analyst · 100% Buy

Live ratings and price targets aggregated across covering analysts.

Buy

1

100%

Hold

0%

Sell

0%

Median Price Target

—

Latest: Citi · Jun 22, 2026

View full analyst page →

vs Industry

How NRC stacks vs Medical - Healthcare Information Services

Stock metrics vs industry averages. Green = better than industry.

Industry comparison data unavailable for this stock.